US Renal Data Systen. USRDS 2008 Annual data report, national institutes of health, national institute of diabetes and digestive and kidney diseases[C]. Bethesda MD, 2008.
Govindarajan G, Saab G, Whaley-Connell A. Outcome sofcarotid revascularization in patientswith chronic kidney disease [J]. Adv Chronic Kidney Dis, 2008, 15(4): 347-354.
[4]
Essig M, Escoubet B, de Zuttere D, et al.Cardiovascular remodeling and extracellular fluid excess in early stages of chronic kidney disease [J]. Nephrol Dial Transplant, 2008, 23(1): 239-248.
[5]
Sch M,Franke S, Muller A, et al. Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein[J].Kidney Int,2004, 66(1):338-347.
[6]
Errier N, Senecal L, Dupuy AM, et al. Association between novel in dices of malnutrition-inflammation complex syndrome and cardiobascular disease in hemodialysis patients[J]. Hemodial Int, 2005,9(2):159-168.
[7]
Kidney Disease Outcome Quality Initiative. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification[J]. Am J Kidney Dis, 2002, 39(Suppl1):261-266.
[8]
George A. The microinflammatory state in uremia: causes and potential consequences[J].J Am Soc Nephrol,2001,12(7):1549-1557.
[9]
Descamps-Latscha B, Heberlin A, Nguyen AT, et al. Banance between IL-1B,TNF-A,and their specificinhibitors in chronic renal failure and maintenance dialysis[J].J Immunol,1995,1549(2):882-892.
[10]
Hkuma T, Minagawa T, Takada N, et al. C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients[J].Am J Kidney Dis, 2003,42(2):355-361.
[11]
Ramirez R,Martin-Malo A,Aljama P.Inflammation and hemodia filtration [J].Contrib Nephro1, 2007,158(5):210-215.
[12]
Roberts MA, Hare DL, Ratnaike S, et al. Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease[J]. Am J Kidney Dis,2006,48:341-360.
[13]
Zoccali C. Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective[J].Kidney Int,2006,70:26-33.
[14]
Bax L, Algra A, Mali WP, et al. Renal function as a risk indicator for cardiovascular events in 3216 patients with manifest arterial disease [J]. Atherosclerosis, 2008, 200(1): 184-190.
